Double maintains 2 strategies that include NVS - Novartis AG
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GSK | 49.45% | $76.56B | -9.39% | 4.02% |
AZN | 48.13% | $223.97B | +8.10% | 2.07% |
AWK | 47.65% | $28.51B | +22.92% | 1.99% |
UL | 44.13% | $150.02B | +22.41% | 2.99% |
ED | 43.11% | $38.69B | +21.90% | 2.95% |
KO | 42.72% | $306.97B | +19.22% | 2.66% |
ABT | 42.61% | $228.81B | +18.56% | 1.69% |
O | 41.89% | $50.94B | +8.24% | 5.57% |
GIS | 41.81% | $32.41B | -14.20% | 3.90% |
WTRG | 41.60% | $10.85B | +9.33% | 3.12% |
POR | 41.24% | $4.89B | +8.04% | 4.47% |
SJW | 40.99% | $1.81B | -1.37% | 2.91% |
ES | 40.87% | $22.99B | +7.19% | 4.61% |
CMS | 40.75% | $22.33B | +25.86% | 2.76% |
WEC | 40.66% | $34.37B | +34.01% | 3.09% |
JNJ | 40.04% | $374.39B | +0.71% | 3.10% |
MSEX | 39.92% | $1.14B | +31.56% | 2.00% |
SO | 39.65% | $100.14B | +28.63% | 3.09% |
AEP | 39.59% | $57.54B | +27.77% | 3.31% |
DUK | 39.57% | $93.55B | +25.45% | 3.37% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
OEF | -<0.01% | $16.66B | 0.2% |
FV | 0.05% | $3.49B | 0.9% |
USXF | 0.09% | $1.25B | 0.1% |
XSW | 0.10% | $460.40M | 0.35% |
DYNF | -0.14% | $15.26B | 0.27% |
PSFF | -0.15% | $438.07M | 0.88% |
JMST | 0.19% | $3.54B | 0.18% |
SGOV | -0.25% | $39.98B | 0.09% |
AIRR | 0.26% | $3.14B | 0.7% |
ULST | -0.27% | $585.14M | 0.2% |
ARGT | 0.28% | $955.09M | 0.59% |
XLY | -0.34% | $19.82B | 0.09% |
KMLM | -0.35% | $218.49M | 0.9% |
RSPT | 0.45% | $3.08B | 0.4% |
FDIS | -0.46% | $1.77B | 0.084% |
KBA | 0.47% | $188.42M | 0.56% |
ONLN | -0.54% | $68.06M | 0.58% |
WEAT | 0.60% | $115.75M | 0.28% |
FTGC | -0.64% | $2.52B | 1.02% |
SPHB | 0.67% | $336.39M | 0.25% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MRVL | -19.19% | $54.76B | -13.42% | 0.42% |
NVDA | -17.82% | $2.69T | +24.12% | 0.04% |
VRT | -17.55% | $29.36B | -9.65% | 0.18% |
ALAB | -17.22% | $10.39B | -7.51% | 0.00% |
GOOGL | -17.12% | $1.91T | +1.37% | 0.53% |
GEV | -16.82% | $91.27B | +140.86% | 0.00% |
CRWD | -16.52% | $92.08B | +16.08% | 0.00% |
GOOG | -16.16% | $1.94T | +1.59% | 0.52% |
CEG | -15.62% | $67.19B | +12.72% | 0.74% |
TLN | -15.39% | $9.77B | +128.68% | 0.00% |
PSTG | -15.33% | $15.00B | -14.05% | 0.00% |
STRL | -15.31% | $3.63B | +10.07% | 0.00% |
COHR | -15.30% | $10.47B | +13.63% | 0.00% |
CDNS | -15.24% | $72.68B | -14.70% | 0.00% |
EME | -15.06% | $17.50B | +6.22% | 0.28% |
MYRG | -14.98% | $1.93B | -31.60% | 0.00% |
CAMT | -14.74% | $2.74B | -26.55% | 0.00% |
AMZN | -14.69% | $2.08T | +7.46% | 0.00% |
PAY | -14.67% | $3.44B | +29.28% | 0.00% |
NVT | -14.65% | $9.06B | -28.26% | 1.61% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UUP | -24.94% | $325.79M | 0.77% |
USDU | -24.89% | $206.96M | 0.5% |
EQLS | -24.46% | $4.80M | 1% |
MAGS | -16.36% | $1.73B | 0.29% |
TESL | -16.11% | $17.90M | 1.2% |
CTA | -13.86% | $978.30M | 0.76% |
VIXY | -13.56% | $195.31M | 0.85% |
CLSE | -13.18% | $170.26M | 1.55% |
YMAG | -12.66% | $302.81M | 1.12% |
FBCG | -12.50% | $3.54B | 0.59% |
FFOG | -12.50% | $109.44M | 0.55% |
FDN | -11.61% | $6.25B | 0.51% |
FBY | -11.52% | $151.21M | 1.06% |
IGM | -11.12% | $5.25B | 0.41% |
EETH | -10.81% | $43.59M | 0.95% |
IYW | -10.80% | $17.75B | 0.39% |
UNG | -10.62% | $397.59M | 1.06% |
CPNJ | -10.17% | $29.63M | 0.69% |
QGRW | -10.15% | $878.13M | 0.28% |
TCHP | -10.12% | $1.01B | 0.57% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GBTG | <0.01% | $3.56B | +24.17% | 0.00% |
REI | <0.01% | $233.95M | -44.02% | 0.00% |
RDUS | -0.01% | $821.24M | +44.52% | 2.58% |
XMTR | 0.02% | $1.26B | +44.34% | 0.00% |
WFRD | 0.02% | $3.95B | -57.08% | 1.61% |
PRMB | 0.02% | $13.21B | +98.62% | 1.07% |
AME | 0.03% | $39.85B | -4.63% | 0.71% |
SSTK | -0.03% | $632.74M | -58.02% | 7.47% |
SMWB | -0.04% | $681.69M | -5.29% | 0.00% |
BLBD | -0.04% | $1.08B | -11.85% | 0.00% |
MOMO | 0.06% | $827.19M | +11.17% | 0.00% |
CMCO | 0.06% | $489.27M | -59.93% | 1.84% |
NGVC | 0.06% | $962.19M | +142.96% | 1.06% |
GDS | 0.07% | $4.97B | +234.61% | 0.00% |
AL | 0.07% | $5.58B | -0.95% | 1.88% |
LMND | 0.08% | $2.33B | +91.79% | 0.00% |
NVEC | 0.08% | $307.79M | -25.80% | 6.80% |
PINS | 0.08% | $21.28B | -11.05% | 0.00% |
AIT | 0.08% | $9.07B | +21.03% | 0.73% |
BBWI | -0.09% | $6.81B | -31.65% | 2.89% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EWL | 62.05% | $1.13B | 0.5% |
PPH | 60.36% | $651.33M | 0.36% |
IXJ | 57.56% | $3.89B | 0.41% |
EFAV | 51.49% | $4.69B | 0.2% |
KXI | 50.54% | $725.04M | 0.41% |
HDEF | 49.75% | $1.85B | 0.09% |
ACWV | 49.21% | $3.38B | 0.2% |
GCOW | 48.78% | $2.19B | 0.6% |
XLV | 48.66% | $37.76B | 0.09% |
DWX | 48.59% | $419.81M | 0.45% |
IYH | 47.95% | $3.15B | 0.39% |
NFRA | 47.62% | $2.42B | 0.47% |
SPHD | 47.06% | $3.55B | 0.3% |
VHT | 46.55% | $16.17B | 0.09% |
FHLC | 46.26% | $2.65B | 0.084% |
LVHD | 46.20% | $547.23M | 0.27% |
HDV | 45.84% | $11.47B | 0.08% |
SDY | 45.43% | $20.07B | 0.35% |
EWU | 45.13% | $3.23B | 0.5% |
SCHY | 45.00% | $924.20M | 0.08% |
SeekingAlpha
Sellas Life Sciences Group, Inc.'s Phase 3 GPS trial sparks uncertainty; stock's a Hold. Interim results for GPS are promising but iffy. Click for more on SLS.
SeekingAlpha
Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain for investors.
SeekingAlpha
AbbVie Vs. Sanofi: Which Is The Better Investment Right Now
SeekingAlpha
Regenxbio Inc. is ranked a Strong Buy due to low EV, strong partnerships, royalty income, bullish trends, and major buyout potential. Click for more on RGNX stock.
SeekingAlpha
The Wasatch Global Value FundâInvestor Class returned -5.78% in the fourth quarter of 2024, underperforming the MSCI AC (All Country) World Value Index, which lost -4.71%.
SeekingAlpha
Lantheus Holdings' stock surges on strong Q4, driven by Pylarify's $1B revenue and strategic growth moves.
Current Value
$114.351 Year Return
Current Value
$114.351 Year Return